home_image.jpg

Pioneering revolutionary, life-saving, and patient-friendly procedures for the early detection of cervical cancers.

MEDITE Cancer Diagnostics, Inc. Becomes New Name for CytoCore, Inc.

CytoCore's goal is to utilize biomolecular research as a basis to develop screening and diagnostic testing products for cancer and cancer-related diseases. We believe that the success of CytoCore's products will improve patient care through more accurate test performance, wider test availability and more cost effective service delivery.

The SoftPAP® cervical cell collector acquires a more complete and comprehensive cervical cell specimen for more consistently reliable Pap test results.  The significantly greater density of captured cells results in fewer false negatives and fewer inadequate specimens.  The unique design eliminates adverse events during collection providing greater patient safety and comfort.
SoftPAP® - unprecedented accuracy, reliability, safety and comfort.